BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33846436)

  • 1. Key biomarkers within the colorectal cancer related inflammatory microenvironment.
    Calu V; Ionescu A; Stanca L; Geicu OI; Iordache F; Pisoschi AM; Serban AI; Bilteanu L
    Sci Rep; 2021 Apr; 11(1):7940. PubMed ID: 33846436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients.
    An S; Kim SK; Kwon HY; Kim CS; Bang HJ; Do H; Kim B; Kim K; Kim Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and secretion of the pro‑inflammatory cytokine IL‑8 is increased in colorectal cancer cells following the knockdown of non‑erythroid spectrin αII.
    Ackermann A; Lafferton B; Plotz G; Zeuzem S; Brieger A
    Int J Oncol; 2020 Jun; 56(6):1551-1564. PubMed ID: 32236629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes.
    Guo G; Wang Y; Zhou Y; Quan Q; Zhang Y; Wang H; Zhang B; Xia L
    J Immunother Cancer; 2019 Jul; 7(1):179. PubMed ID: 31300050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of calprotectin S100A8/A9 complex as a biomarker in colorectal cancer: A systematic review.
    Moris D; Spartalis E; Angelou A; Margonis GA; Papalambros A; Petrou A; Athanasiou A; Schizas D; Dimitroulis D; Felekouras E
    J BUON; 2016; 21(4):859-866. PubMed ID: 27685906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of RAS mutations on the immune infiltrate of colorectal liver metastases: A preliminary study.
    Polidoro MA; Milana F; Soldani C; Franceschini B; Anselmo A; Colombo FS; Di Tommaso L; Cimino M; Carnevale S; Lleo A; Jaillon S; Torzilli G; Donadon M
    J Leukoc Biol; 2020 Aug; 108(2):715-721. PubMed ID: 32108374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with tumor‑associated macrophages promotes PRL‑3‑induced invasion of colorectal cancer cells via MAPK pathway‑induced EMT and NF‑κB signaling‑induced angiogenesis.
    Zhang T; Liu L; Lai W; Zeng Y; Xu H; Lan Q; Su P; Chu Z
    Oncol Rep; 2019 May; 41(5):2790-2802. PubMed ID: 30864736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
    Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
    Lehmann FS; Trapani F; Fueglistaler I; Terracciano LM; von Flüe M; Cathomas G; Zettl A; Benkert P; Oertli D; Beglinger C
    World J Gastroenterol; 2014 May; 20(17):4994-9. PubMed ID: 24803811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory microenvironment in colorectal neoplasia.
    McLean MH; Murray GI; Stewart KN; Norrie G; Mayer C; Hold GL; Thomson J; Fyfe N; Hope M; Mowat NA; Drew JE; El-Omar EM
    PLoS One; 2011 Jan; 6(1):e15366. PubMed ID: 21249124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
    Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
    Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
    Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
    Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients.
    Tutino V; De Nunzio V; Caruso MG; Veronese N; Lorusso D; Di Masi M; Benedetto ML; Notarnicola M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.